Enrico Zambelli is Head of Sustainable Formulations & Project Unit 2 within Global Technical Development at Chiesi Farmaceutici, based in Parma, Italy. In this role, he leads a multidisciplinary team responsible for the development of innovative and sustainable products, with a particular focus on pressurised metered dose inhalers (pMDIs), formulation development, and lifecycle management.
Enrico joined Chiesi 20 years ago and has gained extensive experience across pharmaceutical development, spanning formulation design, process development, technology transfer, and product lifecycle management. Throughout his career, he has been involved in the development of several inhalation products for the treatment of respiratory diseases and has contributed to numerous global development programs from early-stage research through commercialisation.
His current activities focus on enabling the industry's transition towards low Global Warming Potential (GWP) propellants, supporting the development of next-generation pMDIs that combine therapeutic performance with improved environmental sustainability. He is actively involved in strategic initiatives related to propellant technologies, formulation robustness, and sustainable manufacturing approaches.
Enrico is actively engaged in advancing knowledge on formulation robustness, aerosol performance, sustainable pharmaceutical development, and the implementation of novel propellant technologies. His interests include inhalation product development, pharmaceutical formulation science, device-drug combination products, and strategies that support the environmental sustainability of respiratory healthcare.
